PreciseDx Company
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Founded Date:
2019-01-01
Estimated Revenue:
$1M to $10M
Total Funding:
10750000.0
Investors Number:
4.0
Employee Number:
45200
Last Funding Type:
Series A
Industry:
Medical BioTech
Technology:
['BioTech & HealthTech']
Headquarters:
New York, New York, United States
Funding Status:
Early Stage Venture
Last Funding Date:
2022-01-11